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This study aimed to assess whether contractile reserve
evaluation using dobutamine gated single-photon emis-
sion computed tomography (SPECT) improves the capa-
bility of quantitative perfusion analysis to predict func-
tional recovery of viable hibernating myocardium.
Resting and dobutamine nitrate-enhanced technetium-
99m sestamibi (sestamibi) gated SPECT studies were
performed in patients with coronary artery disease who
had left ventricular dysfunction. Tracer activity was
quantified, and wall motion and thickening visually
scored. Reversible dysfunction was identified with gated
SPECT repeated after coronary revascularization. Using
the best activity threshold, perfusion quantification
achieved 85% sensitivity and 55% specificity. Contractile
reserve detection was significantly less sensitive (64%, p
<0.0005), but more specific (88%, p <0.00001) than
perfusion quantification. However, in the subgroup of
hypokinetic segments, the sensitivity of contractile re-
serve assessment was just slightly lower than perfusion
quantification (72% vs 91%, p 5 NS), whereas specific-
ity was significantly higher (94% vs 23%, p <0.00001).
Conversely, in the adyskinetic segments, perfusion
quantification was significantly more sensitive than con-
tractile reserve (82% vs 59%, p <0.005), but similarly
specific (76% vs 85%, p 5 NS). Therefore, the identifi-
cation of reversible dysfunction based on perfusion
quantification in adyskinetic segments and on contractile
reserve detection in hypokinetic segments was signifi-
cantly more specific (83% vs 55%, p <0.00001) than
standard quantitative perfusion SPECT, without major
loss in sensitivity (78% vs 85%, p 5 NS). In conclusion,
contractile reserve evaluation using dobutamine gated
SPECT enhances the reliability of nitrate-enhanced ses-
tamibi SPECT when used to predict reversible dysfunc-
tion in hypokinetic segments, whereas perfusion quan-
tification remains superior in adyskinetic segments.
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Quantitative technetium-99m sestamibi (sesta-mibi) single-photon emission computed tomog-
raphy (SPECT) is a reliable method for the detection
of myocardial viability, particularly when nitrate-en-
hanced imaging is used.1–6 Perfusion imaging with
technetium-labeled agents, however, is increasingly
acquired using the gated SPECT modality, which of-
fers advantages in terms of artifact detection and ad-
ditional functional data.7,8 Great interest has been
given to the implications of gated SPECT for viabil-
ity detection, but no definitive results have been
reached.9–12 An interesting proposal has been to asso-
ciate gated SPECT with low-dose dobutamine infu-
sion to assess the contractile reserve of asynergic
segments.13 The feasibility of this procedure has been
demonstrated,14,15 but its predictive value for pos-
trevascularization outcome and its optimal combina-
tion with quantitative perfusion imaging are still un-
clear. In this study, we used dobutamine gated SPECT
to evaluate the contractile reserve of asynergic seg-
ments with the aim to verify the contribution of func-
tional data to perfusion quantification for the predic-
tion of postrevascularization recovery.
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METHODS
Patient population: We studied 33 consecutive pa-
tients (31 men, mean age 65 6 9 years) who fulfilled
the following inclusion criteria: prior myocardial in-
farction (anterior in 23, inferior in 10 cases), impaired
left ventricular function (mean left ventricular ejection
fraction 33.3 6 9.6% (range 15% to 49%; 17 patients
,35%), and scheduled to undergo revascularization.
Exclusion criteria were: recent (,1 month) myocar-
dial infarction or unstable angina, heart disease other
than coronary artery disease, atrial fibrillation, or his-
tory of sustained ventricular tachycardia. There were
11 patients with 1-vessel, 12 patients with 2-vessel,
and 10 patients with 3-vessel coronary artery disease.
Study protocol: All patients underwent in a single-
session nitrate-enhanced resting and dobutamine ses-
tamibi gated SPECT. To assess functional outcome,
baseline resting sestamibi gated SPECT was repeated
after revascularization: $3 months for bypass grafting
(13 patients) and $1 month for coronary angioplasty
(20 patients). Nitrates and b-adrenergic blocking
agents were discontinued 48 hours before the tests. All
patients gave informed consent to participate in the
study, which was approved by the Ethics Committee
of our institution.
Sestamibi SPECT: The modality of nitrate infusion
has been previously described.4 After 1 hour, baseline
resting gated SPECT was acquired. Immediately
thereafter, dobutamine infusion (5 mg/kg body weight/
min) was started, and increased after 5 minutes to 10
mg/kg/min. Early interruption criteria were hypoten-
sion, angina, or significant ventricular arrhythmia.
Gated SPECT acquisition was started after 3 minutes
of the 10-mg dose that was maintained until acquisi-
tion was completed.16 For the postrevascularization
study, the same dose of sestamibi (1,111 MBq, 30
mCi) was injected, followed 1 hour later by SPECT
acquisition. A dual-head gamma camera (ADAC Ver-
tex, ADAC Laboratories, Milpitas, California) with
high-resolution collimators and a 15% window cen-
tered on the 140-keV photopeak of technetium-99m
was used. SPECT was performed with 32 projections
over a 180° elliptical orbit at 45 s/projection, 64 3 64
matrixes, 8-frames/cardiac cycle. The studies were
reconstructed using filtered back-projection without
attenuation or scatter correction. The reconstructed
slices were realigned along the heart axis and short-,
horizontal long-, and vertical long-axis views were
obtained. For tracer activity quantification, the gated
SPECT images were summed, obtaining a standard
perfusion study.
Data analysis: The left ventricle was divided into
16 segments and each of the segments assigned to the
related coronary territory.17 For tracer activity quan-
tification, the mean uptake of each segment was cal-
culated, the activity of the segment with peak uptake
equated to 100%, and the other segments scaled in
percent of peak activity.6 Regional wall motion and
thickening were assessed visually by consensus of 2
experienced observers, who were blinded to the data,
and scored using a 4-point scale (1 5 normal, 2 5
hypokinesia; 3 5 akinesia; 4 5 dyskinesia).18 Previ-
ous data indicated a good reproducibility of these
evaluations in our laboratory.15 Baseline dysfunc-
tional segments (score . 1) that exhibited a decrease
$1 grade in regional score during dobutamine admin-
istration were considered to have contractile reserve.19
Similarly, functional recovery was defined on the ba-
sis of decrease $1 grade in regional score at follow-
up.19,20 However, a change from dyskinesia to akine-
sia was not considered to be significant.21
Statistical analysis: Receiver operating characteris-
tics curve analysis was used to identify the best cut-off
value of sestamibi activity for predicting functional
recovery. The comparison of proportions was made
using the Fisher’s exact test or the chi-square test with
Yates’ correction, as appropriate. A p value ,0.05
was considered statistically significant.
RESULTS
Baseline and follow-up gated SPECT: Fifty-one vas-
cular territories including 356 segments were success-
fully revascularized. Baseline resting gated SPECT
classified 86 segments as normokinetic, 107 as hypo-
kinetic, and 163 as adyskinetic. After revasculariza-
tion, 109 of 270 dysfunctional segments (43 hypoki-
netic) showed functional recovery, whereas 161 (64
hypokinetic) showed no functional changes.
Myocardial perfusion: According to receiver oper-
ating characteristics curve analysis, the optimal cut-
off value to identify reversible dysfunction in asyner-
gic segments was $50% of peak activity (Figure 1).
Using this threshold, perfusion imaging predicted
functional recovery in 93 of 109 segments (85% sen-
sitivity), and excluded it in 89 of 161 segments (55%
specificity), with 67% global accuracy. In hypokinetic
segments, sensitivity, specificity, and accuracy of ses-
FIGURE 1. Receiver operating characteristics curve constructed
using different sestamibi activity thresholds to define reversible
dysfunction in asynergic segments.
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tamibi SPECT were 91% (39 of 43 segments), 23%
(15 of 64 segments), and 50% (54 of 107 segments),
respectively. In adyskinetic segments, sensitivity,
specificity, and accuracy were 82% (54 of 66 seg-
ments) (p 5 NS vs hypokinetic segments), 76% (74 of
97 segments) (p ,0.00001 vs hypokinetic), and 79%
(128 of 163 segments) (p ,0.00001 vs hypokinetic),
respectively (Figure 2).
Dobutamine gated SPECT: Dobutamine stimulation
elicited contractile reserve in 89 dysfunctional seg-
ments (35 hypokinetic). Of these, 70 segments (31
hypokinetic) showed reversible dysfunction at fol-
low-up (sensitivity 64%, p ,0.0005 vs perfusion
quantification). Only 39 of 181 segments (12 hypoki-
netic) without response to dobutamine showed func-
tional improvement after revascularization (specificity
88%, p ,0.00001 vs perfusion quantification). In hy-
pokinetic segments, contractile reserve showed higher
specificity (94% vs 23%, p ,0.00001) and global
accuracy (85% vs 50%, p ,0.00001) than perfusion
quantification, and similar sensitivity (72% vs 91%,
p 5 NS). In adyskinetic segments, contractile reserve
showed lower sensitivity (59% vs 82%, p ,0.005)
than sestamibi activity, without significant differences
in specificity (85% vs 76%, p 5 NS) or overall accu-
racy (74% vs 79%, p 5 NS) (Figure 2).
Combination of perfusion quantification and contrac-
tile reserve: When adyskinetic segments were consid-
ered to be viable if they had nitrate sestamibi activity
$50%, and hypokinetic segments were considered to
be viable if they had contractile reserve independently
of tracer activity, the specificity (134 of 161 segments,
83%; p ,0.00001) and the global accuracy (219 of
270 segments, 81%; p ,0.0005) improved signifi-
cantly compared with perfusion quantification alone,
whereas sensitivity did not change significantly (85 of
109 segment, 78%), but remained higher than using
contractile reserve alone (70 of 109 segments, 64%, p
,0.03) (Figure 2).
DISCUSSION
For detecting viable hibernating myocardium, the
role of functional imaging, mainly echocardiography,
is to recognize the contractile reserve of asynergic
regions under dobutamine.16,19,21–23 Most recently,
gated SPECT has also been shown to be reliable for
contractile reserve evaluation.14,15 Thus, the simulta-
neous assessment of myocardial cellular integrity us-
ing perfusion imaging and of contractile reserve using
dobutamine gated SPECT has been suggested as a
new approach to viability detection.13 In general, the
demonstration of contractile reserve has a higher spec-
ificity than myocardial perfusion imaging.19,24,25 The
latter approach is usually more sensitive, particularly
in the clinically most important subgroup of akinetic
segments.19 In our series, the higher specificity of
contractile reserve versus perfusion quantification was
confirmed. This finding was particularly conspicuous
in the hypokinetic segments, where the low specificity
of perfusion imaging was explained by tracer uptake
within the layer of viable tissue that sustained con-
tractility. Despite preserved tracer activity, if this tis-
sue coexists with scarred myocardium, contractile re-
serve is absent and functional recovery cannot be
expected. Conversely, hypokinetic segments including
normal tissue and viable hibernating myocardium will
show both contractile reserve during dobutamine and
reversible dysfunction after revascularization. Tracer
activity quantification, however, was significantly
more sensitive than contractile reserve evaluation, es-
pecially in the more severely dysfunctional segments,
as shown by other studies.19 Based on these observa-
tions, we used combined criteria to identify the seg-
ments with reversible dysfunction. Regional dysfunc-
FIGURE 2. Sensitivity, spec-
ificity, and accuracy for
recovery of segmental
function in hypokinetic seg-
ments, adyskinetic seg-
ments, and all asynergic
segments using perfusion
imaging (white bars), con-
tractile reserve (black
bars), and using activity
quantification in adys-
kinetic segments and con-
tractile reserve detection in
hypokinetic segments
(hatched bars).
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tion was assessed on the basis of gated SPECT eval-
uation at rest. If a segment was adyskinetic, it was
classified according to the sestamibi activity value,
using the best cut-off for viability. If a segment was
hypokinetic, it was examined for the presence or ab-
sence of contractile reserve in dobutamine gated
SPECT and classified accordingly as probably viable
or nonviable, respectively. This approach achieved
high sensitivity, specificity, and overall accuracy, and
was significantly superior to perfusion imaging or
contractile reserve evaluation applied separately.
These results support the proposal of taking advantage
of the combination of perfusion and contractile re-
serve data made possible by dobutamine gated
SPECT.13 In contrast, prior studies about the use of
baseline gated SPECT to improve the detection of
viable hibernating myocardium have failed to demon-
strate major diagnostic gains over perfusion images
alone.9–12
The results of the present study must be evaluated
cautiously because of several limitations. As in many
other studies using functional recovery as the refer-
ence standard to define myocardial viability, the pa-
tient population is quite small.9,11,12 A limitation of
gated SPECT compared with echocardiography is the
impossibility to monitor changes during dobutamine
infusion, and so to differentiate between lack of im-
provement and biphasic response, which is considered
the most reliable marker of preserved viability in
dobutamine echocardiography.26,27 Conversely, we
did not perform a quantitative analysis of wall motion
and thickening on gated SPECT images.28,29 This ap-
proach could increase the reliability and reproducibil-
ity of gated SPECT functional assessment and repre-
sents a potential advantage of this method. Finally, we
did not consider the global left ventricular ejection
fraction data, neither to establish the outcome of the
revascularization nor to identify a possible relation
between dobutamine-induced and postrevasculariza-
tion changes. Recent echocardiographic data suggest a
very good accuracy of the dobutamine ejection frac-
tion to predict global functional response after the
intervention.30 Taking into account the good repro-
ducibility of gated SPECT measurements,7 further
studies are warranted to establish the predictive value
of the ejection fraction response to dobutamine.
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